A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00226980 |
|
Recruitment Status :
Completed
First Posted : September 27, 2005
Last Update Posted : April 14, 2009
|
Sponsor:
Stanford University
Collaborator:
Celgene Corporation
Information provided by:
Stanford University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 2005 |
| Actual Study Completion Date : | July 2006 |